FAS and type 2 diabetes mellitus: It has been also shown that Gm15622 regulates the FAS enzyme via the siRNA-dependent knockdown of Gm15622 [129] and that metformin (a first-line medication for type-2 diabetes treatment) administration reduces SREBP-1c, Gm15622, and FAS expressions and increases miR-742-3p level.